LNTH News and Press, Lantheus Holdings Inc.

2026-06-20 23:59:24 ET Investment Thesis Note: This is an update to my previous article . ... Read the full article on Seeking Alpha For further details see: Lantheus: The Turnaround Is Working, But The Easy Money Has Been Made

2026-06-09 11:12:12 ET Lantheus Holdings, Inc. (LNTH) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 8:40 AM EDT... Read the full article on Seeking Alpha For further details see: Lantheus Holdings, Inc. (LNTH) Presents at Goldman Sachs 47th Annual ...

BEDFORD, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, t...

BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that an image generated usi...

BEDFORD, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, to...

2026-05-22 16:09:16 ET More on Lantheus Holdings Lantheus Holdings, Inc. 2026 Q1 - Results - Earnings Call Presentation Lantheus Holdings, Inc. (LNTH) Q1 2026 Earnings Call Transcript Lantheus Holdings: Tensions From The PDUFA Extension Lantheus reiterates $1...

BEDFORD, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced new radiodiagnostic data to be pr...

BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced data to be featured at the 2026 A...

2026-05-11 11:15:06 ET from Truist Financial issued a price target of $115.00 for LNTH on 2026-05-11 13:50:45. The adjusted price target was set to $115.00. At the time of the announcement, LNTH was trading at $94.27. The overall price target consensus is at $99.25 with ...

2026-05-08 11:48:39 ET Image source: The Motley Fool. Thursday, May 7, 2026 at 8 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading